Search

Author/Creator Monnet, Emmanuel

1. A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease. Issue 1 (December 2016)

Authors:
Hatterer, Eric; Shang, Limin; Simonet, Pierre; Herren, Suzanne; Daubeuf, Bruno; Teixeira, Stéphanie; Reilly, James; Elson, Greg; Nelson, Robert; Gabay, Cem; Sokolove, Jeremy; McInnes, Iain; Kosco-Vilbois, Marie; Ferlin, Walter; Monnet, Emmanuel; De Min, Cristina
Journal:
Arthritis research & therapy
Issue:
Volume 18:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study. Issue 3 (31st December 2019)

Authors:
Monnet, Emmanuel; Choy, Ernest H; McInnes, Iain; Kobakhidze, Tamta; de Graaf, Kathy; Jacqmin, Philippe; Lapeyre, Geneviève; de Min, Cristina
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79:Issue 3(2020)
Page Start:
316
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Prognostic biomarkers of IFNb therapy in multiple sclerosis patients. (June 2015)

Authors:
Baranzini, Sergio E; Madireddy, Lohith R; Cromer, Anne; D'Antonio, Mauro; Lehr, Lorenz; Beelke, Manolo; Farmer, Pierre; Battaglini, Marco; Caillier, Stacy J; Stromillo, Maria L; De Stefano, Nicola; Monnet, Emmanuel; Cree, Bruce AC
Journal:
Multiple sclerosis
Issue:
Volume 21:Number 7(2015)
Page Start:
894
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗